Trytosaveabit commented on a stock · Nov 8, 2023 07:47

News!

$AIM ImmunoTech(AIM.US)$ AIM ImmunoTech Announces Encouraging Translational Data from Phase 2 Study Evaluating Ampligen® for the Treatment of Advanced Recurrent Ovarian Cancer 1 MINUTE AGO, 8:45 AM EST VIA GLOBENEWSWIRE

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

2025 Views

Comment

Trytosaveabit

1841Followers

30Following

22KVisitors